Organization · Venture Capital
METIS Innovative
METIS Innovative is a physician-founded investment firm focused on early-stage medical devices and technologies in the neurosciences. Established in 2017, it combines clinical insights from neurosurgeons with financial analysis to identify high-potential opportunities.
Overview
What METIS Innovative does
What METIS Innovative is
METIS Innovative is a physician-founded investment firm focused on early-stage medical devices and technologies in the neurosciences. Established in 2017, it combines clinical insights from neurosurgeons with financial analysis to identify high-potential opportunities.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find METIS Innovative elsewhere
Open the official website or a supported primary organization account.
Capability profile
METIS Innovative as a funder
Investment thesis
METIS Innovative invests in promising early-stage medical devices and technology in the neurosciences, aiming to improve treatment options for individuals suffering from neurologic illnesses.
Focus narrative
METIS Innovative invests in early-stage companies developing medical devices and technologies aimed at treating neurologic conditions. Their investment strategy combines clinical insights from practicing neurosurgeons with financial analysis to identify high-potential opportunities in the neurotechnology space.
Value beyond capital
METIS Innovative leverages clinical insights from practicing neurosurgeons to provide unique value to portfolio companies, ensuring that investments are not only financially sound but also clinically viable. Their expertise in the neurosciences sector helps startups navigate the complexities of medical device development and market entry.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B
- Sectors
- Medical Devices
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Synchron: A leader in the implantable brain-computer-interface (BCI) space, conducting human clinical studies for their proprietary product. Fluid Biomed: Developing the first polymer-based brain stent to cure aneurysms, addressing a condition that affects up to 5% of the population. Proprio: A technology company focused on modernizing surgical practices through immersive and intelligent technology. Precision Recovery: Provides comprehensive virtual care for stroke recovery, helping patients manage their recovery from home. Aurenar: Creating a disposable, wearable neuromodulation device for critically ill patients. Phantom Neuro: Works on enhancing the interaction between humans and machines to improve lives. Reach Neuro: Develops technology to restore movement for stroke survivors. Von Vascular: Innovates in medical devices, particularly in thrombectomy technologies.
Common questions
What to know about METIS Innovative
Upseed classifies METIS Innovative under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.